Shaping of an effective immune microenvironment to and by cancer cells (Q38238941)

31 August 2017

title

Shaping of an effective immune microenvironment to and by cancer cells (English)

1 reference

Marie-Caroline Dieu-Nosjean

31 August 2017

author

5

Marie-Caroline Dieu-Nosjean

0 references

Catherine Sautès-Fridman

6

Catherine Sautès-Fridman

0 references

Wolf Hervé Fridman

7

Wolf-Herman Fridman

0 references

Nicolas A Giraldo

Nicolas A Giraldo

4

0 references

Jeremy Goc

Jeremy Goc

2

0 references

Etienne Becht

1

Etienne Becht

1 reference

31 August 2017

Claire Germain

3

1 reference

31 August 2017

Wolf-Herman Fridman

7

1 reference

31 August 2017

publication date

12 August 2014

1 reference

Cancer Immunology, Immunotherapy

31 August 2017

published in

1 reference

31 August 2017

volume

63

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

991-997

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Cancer classification using the Immunoscore: a worldwide task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

21 January 2018

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Modulation of immunity by antiangiogenic molecules in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

The immune contexture of primary and metastatic human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Tertiary lymphoid organs in infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

Cancer risk after renal transplantation in the nordic countries, 1964-1986

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1590-3

10.1007/S00262-014-1590-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1047791171

0 references

1 reference